Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection
Mark M. Painter(Translational Therapeutics (United States)), Timothy S. Johnston(National Institutes of Health), Kendall A. Lundgreen(University of Pennsylvania), Jefferson Santos(University of Pennsylvania), Juliana S. Qin(University of Pennsylvania), Rishi R. Goel(Translational Therapeutics (United States)), Sokratis A. Apostolidis(Translational Therapeutics (United States)), Divij Mathew(Translational Therapeutics (United States)), Bria Fulmer(Translational Therapeutics (United States)), Justine C. Williams(University of Pennsylvania), Michelle L. McKeague(University of Pennsylvania), Ajinkya Pattekar(University of Pennsylvania), Ahmad Goode(University of Pennsylvania), Sean Nasta(University of Pennsylvania), Amy E. Baxter(Translational Therapeutics (United States)), Josephine R. Giles(Parker Institute for Cancer Immunotherapy), Ashwin N. Skelly(University of Pennsylvania), Laura E Felley(University of Michigan), M. A. McLaughlin(Translational Therapeutics (United States)), JoEllen Weaver(University of Pennsylvania), Penn Medicine BioBank(Translational Therapeutics (United States)), Marylyn D. Ritchie(University of Pennsylvania Health System), Michael D. Feldman(University of Pennsylvania Health System), JoEllen Weaver(University of Pennsylvania), Nawar Naseer(University of Pennsylvania Health System), Afiya Poindexter(University of Pennsylvania Health System), Ashlei Brock(La Jolla Institute for Immunology), Khadijah Hu-Sain(La Jolla Institute for Immunology), Yi-An Ko(La Jolla Institute for Immunology), Meghan Livingstone(La Jolla Institute for Immunology), Fred Vadivieso(Parker Institute for Cancer Immunotherapy), Ashley Kloter(University of Pennsylvania Health System), Stephanie DerOhannessian(University of Pennsylvania Health System), Teo Tran(University of Pennsylvania Health System), Linda Morrel(Translational Therapeutics (United States)), Ned Haubein(Parker Institute for Cancer Immunotherapy), Joseph Dunn(University of Pennsylvania Health System), Anurag Verma(University of Pennsylvania Health System), Colleen Morse(University of Pennsylvania Health System), Marjorie Risman(University of Pennsylvania Health System), Renae Judy(University of Pennsylvania Health System), Shefali S. Verma(University of Pennsylvania Health System), Yuki Bradford(University of Pennsylvania Health System), Scott Dudek(University of Pennsylvania Health System), Theodore Drivas(University of Pennsylvania Health System), Oliva Kuthuru(Translational Therapeutics (United States)), Jeanette Dougherty(University of Pennsylvania), Sharon Adamski(University of Pennsylvania), Sherea Long(University of Pennsylvania), Macy Kee(University of Pennsylvania), Cynthia Clendenin(University of Pennsylvania), Ricardo da Silva Antunes(La Jolla Institute for Immunology), Alba Grifoni(La Jolla Institute for Immunology), Daniela Weiskopf(La Jolla Institute for Immunology), Alessandro Sette(La Jolla Institute for Immunology), Alexander C. Huang(Parker Institute for Cancer Immunotherapy), Daniel J. Rader(University of Pennsylvania Health System), Scott E. Hensley(University of Pennsylvania), Paul Bates(University of Pennsylvania), Allison R. Greenplate(Translational Therapeutics (United States)), E. John Wherry(Parker Institute for Cancer Immunotherapy)
Cited by 106Open Access